Joel Greenblatt Nevro Corp Transaction History

Gotham Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $266,668 - $355,776	-1,930 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $1.1 Million - $1.41 Million	-9,677 Reduced 83.37%	1,930 $269,000
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $424,171 - $615,748	4,742 Added 69.08%	11,607 $1.39 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $18,681 - $38,386	266 Added 4.03%	6,865 $686,000
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $504,229 - $775,646	6,599 New	6,599 $776,000
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $696,440 - $890,035	-9,622 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $668,344 - $852,220	9,622 New	9,622 $834,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.